Search

Search Constraints

You searched for: Author/Creator Gennari, William

Search Results

1. A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients. (16th November 2020)

2. Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice. (September 2022)

3. Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study. Issue 7 (July 2017)

4. Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE). Issue 12 (2nd December 2019)

5. COVID-19 Rapid Antigen Test Screening in Patients on Hemodialysis. (14th September 2022)

6. Cytomegalovirus reactivation after hematopoietic stem cell transplant with CMV‐IG prophylaxis: A monocentric retrospective analysis. Issue 11 (19th February 2021)

7. Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding. (1st November 2021)

8. Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding. (1st November 2021)

9. Immunophenotypic profile and clinical outcome of monoclonal B‐cell lymphocytosis in kidney transplantation. Issue 8 (26th August 2018)

10. Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy. (24th January 2020)